DURECT Appoints Two New Board Members

CUPERTINO, Calif., April 25, 2019 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) announced today the appointment of two new members to its board of directors. Dr. Gail M. Farfel, Executive Vice President and Chief Developm... Biopharmaceuticals, Drug Delivery, Personnel DURECT, PERSERIS, risperidone, Schizophrenia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news